Icahn School Of Medicine At Mount Sinai

Cardiovascular medicine

The clinical research activity centers on atrial fibrillation arising after coronary artery bypass grafting, with attention to post-operative cardiac arrhythmia and its clinical consequences.

  • New-onset post-operative atrial fibrillation
  • Coronary bypass surgery
  • Cardiac rhythm disturbance

Interest is focused on the management of rhythm-related complications in surgical cardiac care.

Thrombosis prevention

Research activity addresses the prevention of thromboembolic events associated with atrial fibrillation, with emphasis on reducing clot-related complications after cardiac surgery.

  • Thromboembolism
  • Blood clot prevention
  • Anticoagulation

The therapeutic domain includes strategies to limit embolic risk in patients with newly developed arrhythmia.

Antithrombotic therapy

The funded trial landscape includes evaluation of oral anticoagulation alongside antiplatelet therapy, reflecting interest in balancing clot prevention with bleeding risk in post-surgical cardiovascular care.

  • Oral anticoagulants
  • Antiplatelet therapy
  • Bleeding risk

This area links medication management with safety considerations in patients recovering from bypass surgery.

Perioperative cardiac care

Clinical interest extends to the period following isolated CABG surgery, where new arrhythmias and related complications require careful medical management in a surgical recovery setting.

  • Post-operative care
  • Cardiac surgery recovery
  • Arrhythmia management

The research focus remains on complications emerging during the immediate recovery period after heart bypass procedures.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination

    Recruiting

    3 1 1 1
    Investigated diseases:
    Germany